The company plans to introduce Beyfortus, which contains the monoclonal antibody, nirsevimab, in a prefilled injection used ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

Dr. Reddy’s Laboratories will expand its partnership with Sanofi Healthcare India (SHIPL) by launching the latter’s novel drug Beyfortus (nirsevimab) in India.

RSV is a major respiratory pathogen, particularly among young children, causing severe lower respiratory tract diseases. While current models, such as HEp-2 cells, are commonly used for RSV ...

Cathay Pacific Airways , one of Asia's largest air freight carriers, expects air cargo demand between mainland China and the ...

“It prevents the upper jaw from expanding properly and can cause the lower jaw to not grow forward enough, which can ultimately lead to airway obstruction.” In addition to the functional ...

A Chinese man's bizarre habit of sniffing his dirty socks landed him in the hospital after it led to him developing a serious ...

The Supreme Court today rejected an appeal filed by EVA Airways Corp (長榮航空), upholding a decision made by the High Court last ...

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Etihad Airways announced on Friday the launch of its first career fair, in an attempt to connect ambitious Emirati talent ...